ES2090970T3 - Procedimiento para la preparacion de derivados del taxano. - Google Patents

Procedimiento para la preparacion de derivados del taxano.

Info

Publication number
ES2090970T3
ES2090970T3 ES93904150T ES93904150T ES2090970T3 ES 2090970 T3 ES2090970 T3 ES 2090970T3 ES 93904150 T ES93904150 T ES 93904150T ES 93904150 T ES93904150 T ES 93904150T ES 2090970 T3 ES2090970 T3 ES 2090970T3
Authority
ES
Spain
Prior art keywords
stands
iii
general formula
hydroxy function
taxane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93904150T
Other languages
English (en)
Inventor
Elie Fouque
Jean-Manuel Mas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2090970T3 publication Critical patent/ES2090970T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCESO DE PREPARACION DE DERIVADOS DE TAXANO DE FORMULA GENERAL (I) POR ESTERIFICACION A UNA TEMPERATURA COMPRENDIDA ENTRE 10 Y 60 (GRADOS) C DE UN DERIVADO DE BACATINA III O DE LA DESACETIL10-BACATINA III DE FORMULA GENERAL (II) MEDIANTE UN ACIDO DE FORMULA GENERAL (III) SEGUIDA DE LA SUSTITUCION DE LOS GRUPOS PROTECTORES G1, G2 Y R2 DEL PRODUCTO OBTENIDO POR ATOMOS DE HIDROGENO. EN LAS FORMULAS (I), (II) O (III): AR REPRESENTA UN RADICAL ARILO; R REPRESENTA HIDROGENO O ACETILO; R1 REPRESENTA BENZOILO O TER.BUTOXICARBONILO; G1 REPRESENTA UN GRUPO PROTECTOR HIDROXI, G2 REPRESENTA EL RADICAL ACETILO O UN GRUPO PROTECTOR DE LA FUNCION HIDROXI Y R2 REPRESENTA UN GRUPO PROTECTOR DE LA FUNCION HIDROXI.
ES93904150T 1992-02-07 1993-02-04 Procedimiento para la preparacion de derivados del taxano. Expired - Lifetime ES2090970T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201379A FR2687150B1 (fr) 1992-02-07 1992-02-07 Procede de preparation de derives du taxane.

Publications (1)

Publication Number Publication Date
ES2090970T3 true ES2090970T3 (es) 1996-10-16

Family

ID=9426424

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93904150T Expired - Lifetime ES2090970T3 (es) 1992-02-07 1993-02-04 Procedimiento para la preparacion de derivados del taxano.

Country Status (24)

Country Link
US (1) US6596880B1 (es)
EP (1) EP0625147B1 (es)
JP (1) JP3295879B2 (es)
KR (1) KR100254167B1 (es)
AT (1) ATE141920T1 (es)
AU (1) AU686095B2 (es)
CA (1) CA2126462C (es)
CZ (1) CZ283377B6 (es)
DE (1) DE69304309T2 (es)
DK (1) DK0625147T3 (es)
ES (1) ES2090970T3 (es)
FI (1) FI106959B (es)
FR (1) FR2687150B1 (es)
GR (1) GR3020894T3 (es)
HU (1) HU212577B (es)
MX (1) MX9300622A (es)
NO (1) NO305863B1 (es)
NZ (1) NZ249162A (es)
PL (1) PL175106B1 (es)
RU (1) RU2103266C1 (es)
SK (1) SK280012B6 (es)
TW (1) TW234122B (es)
WO (1) WO1993016059A1 (es)
ZA (1) ZA93823B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
US5684175A (en) * 1993-02-05 1997-11-04 Napro Biotherapeutics, Inc. C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor
US5948919A (en) * 1993-02-05 1999-09-07 Napro Biotherapeutics, Inc. Paclitaxel synthesis from precursor compounds and methods of producing the same
DE69433297T2 (de) * 1993-02-05 2004-10-21 Bryn Mawr College Bryn Mawr Synthese von taxol, seinen analogen und intermediaten mit variablen a-ring seitenketten
EP0700910A1 (en) * 1994-09-06 1996-03-13 Shionogi & Co., Ltd. Process for isolation of taxol from Taxus sumatrana
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
US5675025A (en) * 1995-06-07 1997-10-07 Napro Biotherapeutics, Inc. Paclitaxel synthesis from precursor compounds and methods of producing the same
US6107332A (en) 1995-09-12 2000-08-22 The Liposome Company, Inc. Hydrolysis-promoting hydrophobic taxane derivatives
US6051600A (en) * 1995-09-12 2000-04-18 Mayhew; Eric Liposomal hydrolysis-promoting hydrophobic taxane derivatives
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis
US5750737A (en) * 1996-09-25 1998-05-12 Sisti; Nicholas J. Method for paclitaxel synthesis
PT1178979E (pt) * 1999-05-17 2004-04-30 Bristol Myers Squibb Co Novas condicoes de reaccao para a clivagem de eteres de sililo na preparacao de paclitaxel (taxol(r)) e analogos de paclitaxel
EP1200424B1 (en) 2000-02-02 2008-11-05 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
KR20010112395A (ko) 2000-02-02 2001-12-20 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서의 ｃ７ 카르보네이트 치환된 탁산
US6452025B1 (en) 2001-04-25 2002-09-17 Napro Biotherapeutics, Inc. Three-step conversion of protected taxane ester to paclitaxel
EP1730522A2 (en) * 2004-03-29 2006-12-13 Howard Murad Methods for treating dermatological conditions in a patient
CN100586940C (zh) * 2007-01-26 2010-02-03 上海百灵医药科技有限公司 紫杉醇和多烯紫杉醇的半合成方法
KR101014438B1 (ko) * 2008-09-26 2011-02-14 동아제약주식회사 탁산 유도체의 제조방법
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
WO2012131698A1 (en) * 2011-04-01 2012-10-04 Shilpa Medicare Limited Process for preparing docetaxel and its hydrate
CN108686203A (zh) 2012-04-04 2018-10-23 哈洛齐梅公司 使用抗透明质酸剂和肿瘤靶向紫杉烷的组合疗法
EP2861256B1 (en) 2012-06-15 2019-10-23 The Brigham and Women's Hospital, Inc. Compositions for treating cancer and methods for making the same
WO2015153345A1 (en) 2014-04-03 2015-10-08 Invictus Oncology Pvt. Ltd. Supramolecular combinatorial therapeutics
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR336840A (fr) 1903-10-29 1904-03-18 Emmanuel Saura Machine à piston diviseur
FR336841A (fr) 1903-10-29 1904-03-18 James William Mander Perfectionnements apportés aux instruments employés pour le dessin
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol

Also Published As

Publication number Publication date
SK280012B6 (sk) 1999-07-12
HU9402289D0 (en) 1994-10-28
EP0625147B1 (fr) 1996-08-28
FR2687150B1 (fr) 1995-04-28
WO1993016059A1 (fr) 1993-08-19
AU686095B2 (en) 1998-02-05
JP3295879B2 (ja) 2002-06-24
CZ283377B6 (cs) 1998-04-15
NO305863B1 (no) 1999-08-09
ZA93823B (en) 1993-09-16
HUT68773A (en) 1995-07-28
KR950700267A (ko) 1995-01-16
NO942895L (no) 1994-08-04
GR3020894T3 (en) 1996-11-30
SK93094A3 (en) 1995-04-12
MX9300622A (es) 1993-08-01
CZ187094A3 (en) 1994-12-15
US6596880B1 (en) 2003-07-22
NZ249162A (en) 1996-10-28
TW234122B (es) 1994-11-11
FR2687150A1 (fr) 1993-08-13
FI943643A0 (fi) 1994-08-05
JPH07503472A (ja) 1995-04-13
FI106959B (fi) 2001-05-15
EP0625147A1 (fr) 1994-11-23
AU3504893A (en) 1993-09-03
KR100254167B1 (ko) 2000-05-01
FI943643A (fi) 1994-08-05
CA2126462A1 (fr) 1993-08-19
NO942895D0 (es) 1994-08-04
RU94040356A (ru) 1997-05-27
PL175106B1 (pl) 1998-11-30
DK0625147T3 (da) 1996-11-11
RU2103266C1 (ru) 1998-01-27
CA2126462C (fr) 2002-07-09
DE69304309D1 (de) 1996-10-02
HU212577B (en) 1996-08-29
ATE141920T1 (de) 1996-09-15
DE69304309T2 (de) 1997-01-23

Similar Documents

Publication Publication Date Title
ES2090970T3 (es) Procedimiento para la preparacion de derivados del taxano.
FR2678930B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
ES2186672T3 (es) Procedimiento para la produccion de derivados 13-eter de milbemicinas, e intermedios de los mismos.
NO923677L (no) Nye furyl- og thienylsubstituerte taksaner og farmasoeytiske preparater som inneholder slike
DK81885A (da) Pyrido-benzothiazinderivater, fremgangsmaade til fremstilling deraf ogfarmaceutisk praeparat indeholdende mindst et saadant derivat
ATE60763T1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
ATE138571T1 (de) Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.
EE03071B1 (et) Karbasolooni derivaadid ja nende saamise protsess
FR2677023B1 (fr) Derives de coumarine hydrosolubles, leur preparation et leur utilisation comme substrat d'enzyme.
NO900636L (no) Fremgangsmaate for fremstilling av indolderivater.
DK508484D0 (da) N-substituerede isoquinolinderivater og farmaceutisk praeparat indeholdende dem

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 625147

Country of ref document: ES

FG2A Definitive protection

Ref document number: 625147

Country of ref document: ES